Your browser doesn't support javascript.
loading
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Fanouriakis, Antonis; Kostopoulou, Myrto; Andersen, Jeanette; Aringer, Martin; Arnaud, Laurent; Bae, Sang-Cheol; Boletis, John; Bruce, Ian N; Cervera, Ricard; Doria, Andrea; Dörner, Thomas; Furie, Richard A; Gladman, Dafna D; Houssiau, Frederic A; Inês, Luís Sousa; Jayne, David; Kouloumas, Marios; Kovács, László; Mok, Chi Chiu; Morand, Eric F; Moroni, Gabriella; Mosca, Marta; Mucke, Johanna; Mukhtyar, Chetan B; Nagy, György; Navarra, Sandra; Parodis, Ioannis; Pego-Reigosa, José M; Petri, Michelle; Pons-Estel, Bernardo A; Schneider, Matthias; Smolen, Josef S; Svenungsson, Elisabet; Tanaka, Yoshiya; Tektonidou, Maria G; Teng, Yk Onno; Tincani, Angela; Vital, Edward M; van Vollenhoven, Ronald F; Wincup, Chris; Bertsias, George; Boumpas, Dimitrios T.
Afiliação
  • Fanouriakis A; Rheumatology and Clinical Immunology Unit, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Kostopoulou M; Rheumatology and Clinical Immunology Unit, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Andersen J; Lupus Europe, Copenhagen, Denmark.
  • Aringer M; Division of Rheumatology, Department of Medicine III, University Medical Center & Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany.
  • Arnaud L; Department of Rheumatology, Hôpitaux Universitaires de Strasbourg, INSERM UMR-S 1109, Centre National de Référence des Maladies Auto-immunes Systémiques Rares (RESO), Strasbourg, France.
  • Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology Research and Hanyang Institute of Bioscience and Biotechnology, Seoul, South Korea.
  • Boletis J; Department of Nephrology and Renal Transplantation Unit, "Laiko" General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Bruce IN; Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, UK; National Institute for Health Research Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Cervera R; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain.
  • Doria A; Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Dörner T; Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin; Deutsches Rheumaforschungszentrum, Berlin, Germany.
  • Furie RA; Division of Rheumatology, Northwell Health, Great Neck, New York City, New York, USA.
  • Gladman DD; Lupus Program, Centre for Prognosis Studies in the Rheumatic Disease, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Houssiau FA; Service de Rhumatologie, Cliniques Universitaires Saint-Luc and Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
  • Inês LS; Department of Rheumatology, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal; School of Health Sciences, Universidade da Beira Interior, Covilha, Portugal.
  • Jayne D; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Kouloumas M; Cyprus League Against Rheumatism, Aglantzia, Cyprus.
  • Kovács L; Department of Rheumatology and Immunology, Faculty of Medicine, University of Szeged, Hungary.
  • Mok CC; Department of Medicine, Tuen Mun Hospital, Hong Kong, China.
  • Morand EF; Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.
  • Moroni G; Department of Biomedical Sciences Humanitas University, Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Mosca M; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Mucke J; Department of Rheumatology & Hiller Research Unit Rheumatology, UKD, Heinrich-Heine University, Düsseldorf, Germany.
  • Mukhtyar CB; Vasculitis Service, Rheumatology Department, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
  • Nagy G; Hospital of the Hospitaller Order of Saint John of God, Budapest, Hungary.
  • Navarra S; Department of Rheumatology and Clinical Immunology, Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Parodis I; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Pego-Reigosa JM; Section of Rheumatology, Department of Medicine, University of Santo Tomas, Manila, Philippines.
  • Petri M; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Pons-Estel BA; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
  • Schneider M; Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Smolen JS; Rheumatology Department, Complejo Hospitalario Universitario de Vigo, IRIDIS (Investigation in Rheumatology and Immune-Mediated Diseases) - VIGO Group, Galicia Sur Health Research Institute, Vigo, Spain.
  • Svenungsson E; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Tanaka Y; Grupo Oroño, Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
  • Tektonidou MG; Department of Rheumatology & Hiller Research Unit Rheumatology, UKD, Heinrich-Heine University, Düsseldorf, Germany.
  • Teng YO; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.
  • Tincani A; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Vital EM; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
  • van Vollenhoven RF; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Wincup C; Rheumatology Unit, First Department of Propaedeutic Internal Medicine, "Laiko" General Hospital, Medical School, National and Kapodistrian University of Athens, Joint Academic Rheumatology Program, Athens, Greece.
  • Bertsias G; Centre of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic autoimmune diseases, Department of Internal Medicine - section Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
  • Boumpas DT; Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy.
Ann Rheum Dis ; 83(1): 15-29, 2024 Jan 02.
Article em En | MEDLINE | ID: mdl-37827694
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Azatioprina / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Grécia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Azatioprina / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Grécia